Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis
Title:
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis
Author:
Shaaban, Ahmed A. Abdelhamid, Amir Mohamed Shaker, Mohamed E. Cavalu, Simona Maghiar, Adrian Marius Alsayegh, Abdulrahman A. Babalghith, Ahmad O. El-Ahwany, Eman Amin, Noha A. Mohammed, Osama A. Eissa, Hanan Gaafar, Ahmed Gaafar Ahmed Batiha, Gaber El-Saber Saber, Sameh